Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy

European Journal of Anaesthesiology

Volumn 28, Issue 1, 2011, Pages 57-62

  Weber, Christian F ^a   Görlinger, Klaus ^b   Byhahn, Christian ^a   Moritz, Anton ^a   Hanke, Alexander A ^c   Zacharowski, Kai ^a   Meininger, Dirk ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Aspirin; Clopidogrel; Platelet aggregation inhibitors; Platelet function test; Tranexamicxs acid

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CLOPIDOGREL; THROMBIN RECEPTOR ACTIVATING PEPTIDE 6; TRANEXAMIC ACID;

AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MALE; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; STIMULATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT DURATION;

AGED; ANTIFIBRINOLYTIC AGENTS; ASPIRIN; CORONARY ARTERY BYPASS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROSPECTIVE STUDIES; TICLOPIDINE; TRANEXAMIC ACID;

EID: 79951486084     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32834050ab     Document Type: Article

References (35)

1. Flordal PA. Use of desmopressin to prevent bleeding in surgery. Eur J Surg 1998; 164:5-11. (Pubitemid 28067169)
2. Valeri CR, Feingold H, Cassidy G, et al. Hypothermia-induced reversible platelet dysfunction. Ann Surg 1987; 205:175-181. (Pubitemid 17028630)
3. Valeri CR, Cassidy G, Pivacek LE, et al. Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion 2001; 41:977-983. (Pubitemid 33642786)
4. Franz A, Braunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001; 92:1402-1407. (Pubitemid 32493149)
5. Paparella D, Brister SJ, Buchanan MR. Coagulation disorders of cardiopulmonary bypass: a review. Intensive Care Med 2004; 30:1873-1881. (Pubitemid 39468407)
6. Holmes DR Jr, Kereiakes DJ, Kleiman NS, et al. Combining antiplatelet and anticoagulant therapies. J Am Coll Cardiol 2009; 54:95-109.
7. Spiess BD, Royston D, Levy JH, et al. Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion 2004; 44:1143-1148. (Pubitemid 38989746)
8. Karkouti K, Wijeysundera DN, Yau TM, et al. Platelet transfusions are not associated with increased morbidity or mortality in cardiac surgery. Can J Anaesth 2006; 53:279-287.
9. Pereboom IT, de Boer MT, Haagsma EB, et al. Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury. Anesth Analg 2009; 108:1083-1091.
10. Soslau G, Horrow J, Brodsky I. Effect of tranexamic acid on platelet ADP during extracorporeal circulation. Am J Hematol 1991; 38:113-119.
11. Koscielny J, Pruss A, Kiesewetter H, Klinischer Einsatz von Desmopressin und Antifibrinolytika in der perioperativen Intensivmedizin. In: Intensivmedizin. 15. Ergänzungslieferung Oktober 2005. Landsberg, Germany: ecomed Medizin Verlagsgruppe, 2005.
12. Weber CF, Schneider AC, Kirschning T, et al. Therapeutic options for perioperatively acquired platelet dysfunctions. Anaesthesist 2009; 58:931-932; 934-936, 938-940.
13. Henry DA, Carless PA, Moxey AJ, et al. Antifibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2007:CD001886.
14. Mengistu AM, Rohm KD, Boldt J, et al. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Anesth Analg 2008; 107:391-397.
15. Kickler T. Alternatives to platelet transfusion in the management of platelet dysfunction or thrombocytopenia. Transfus Altern Transfus Med 2006; 8:127-134.
16. Pleym H, Stenseth R, Wahba A, et al. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg 2003; 96:923-928. (Pubitemid 36359017)
17. Toth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96:781-788. (Pubitemid 44883819)
18. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3:135-158. (Pubitemid 10052139)
19. Weber CF, Dietrich W, Spannagl M, et al. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery. Anesth Analg 2010; 110:702-707.
20. Key NS, Negrier C. Coagulation factor concentrates: past, present, and future. Lancet 2007; 370:439-448. (Pubitemid 47176658)
21. Eikelboom JW, Hankey GJ. Aspirin resistance: a new independent predictor of vascular events? J Am Coll Cardiol 2003; 41:966-968. (Pubitemid 36315538)
22. Paniccia R, Antonucci E, Maggini N, et al. Comparison of methods for monitoring residual platelet reactivity after clopidogrel by point-of-care tests on whole blood in high-risk patients. Thromb Haemost 2010; 104:287-292.
23. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007; 18:199-206. (Pubitemid 46744118)
24. Mengistu AM, Mayer J, Boldt J, Rohm KD. Whole-blood aggregometry: are there any limits with regard to platelet counts? Acta Anaesthesiol Scand 2009; 53:72-76.
25. Sabovic M, Zupan IP, Salobir B, et al. The effect of long-term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients. Thromb Haemost 2005; 94:1245-1250. (Pubitemid 41819623)
26. Mezzano D, Panes O, Munoz B, et al. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Thromb Haemost 1999; 82:1250-1254. (Pubitemid 29473787)
27. Mao Y, Jin J, Daniel JL, Kunapuli SP. Regulation of plasmin-induced protease-activated receptor 4 activation in platelets. Platelets 2009; 20:191-198.
28. Amara U, Rittirsch D, Flierl M, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol 2008; 632:71-79.
29. Fitch JC, Rollins S, Matis L, et al. Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass. Circulation 1999; 100:2499-2506. (Pubitemid 30005113)
30. Warren OJ, Smith AJ, Alexiou C, et al. The inflammatory response to cardiopulmonary bypass. Part 1: Mechanisms of pathogenesis. J Cardiothorac Vasc Anesth 2009; 23:223-231.
31. Videm V, Svennevig JL, Fosse E, et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103:806-813.
32. Van Oeveren W, Harder MP, Roozendaal KJ, et al. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99:788-796; discussion 796-787.
33. de Haan J, van Oeveren W. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/ IX complexes: protection by aprotinin. Thromb Res 1998; 92:171-179. (Pubitemid 28541063)
34. Lindvall G, Sartipy U, Bjessmo S, et al. Aprotinin reduces the antiplatelet effect of clopidogrel. Interact Cardiovasc Thorac Surg 2009; 9:178-181.
35. Cardone D, Klein AA. Perioperative blood conservation. Eur J Anaesthesiol 2009; 26:722-729.